BioVaxys Technology Corp. Closes Listed Issuer Financing Exemption (LIFE) Private Placement

  VANCOUVER, BC, November 19, 2025 – TheNewswire - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or the “Company”) announces that it has closed its previously announced non-brokered private placement financing (the “Offering”) of 11,311,676 units of the Company (the “Units”) at an issue price of $0.17 per Unit for aggregate gross proceeds of $1,922,984.92.  Each Unit consists of one common share of the Company (“Share”) and one common share purchase warrant (“Warrant”), whereby each Warrant ...